Cvent Reinforces Commitment to Data Privacy and Information Security by Renewing ISO 27001 and Obtaining ISO 27701 Certifications
May 25, 2021 08:54 ET | Cvent
Tysons, VA, May 25, 2021 (GLOBE NEWSWIRE) -- Cvent, a market-leading meetings, events, and hospitality technology provider, announced today that the company has renewed its ISO 27001 (data security)...
Bone Therapeutics annonce sa participation à plusieurs conférences
May 20, 2021 01:00 ET | Bone Therapeutics SA
Gosselies, Belgique, le 20 mai 2021, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires...
Bone Therapeutics to participate in upcoming conferences
May 20, 2021 01:00 ET | Bone Therapeutics SA
Gosselies, Belgium, 20 May 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today...
Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Pressrelease 12 maj 2021 Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget kommer att...
Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Press Release 12 May 2021 Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) today announced that it will be...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in May
May 03, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 03, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Immunicum AB presenterar prekliniska data från studier med Ilixadencel och DCP-001 vid det 18:e årsmötet för cancerimmunoterapi (CIMT)
May 03, 2021 02:00 ET | Immunicum AB
Pressrelease 3 maj 2021 Immunicum AB presenterar prekliniska data från studier med Ilixadencel och DCP-001 vid det 18:e årsmötet för cancerimmunoterapi (CIMT) ...
Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting
May 03, 2021 02:00 ET | Immunicum AB
Press Release 03 May 2021 Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting Immunicum AB (publ;...
TBIO.jpg
Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit
April 28, 2021 07:30 ET | Translate Bio, Inc.
LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
Immunicum tillkännager presentationer vid kommande vetenskapliga möten i april och maj
April 19, 2021 02:00 ET | Immunicum AB
Pressrelease 19 april 2021 Immunicum tillkännager presentationer vid kommande vetenskapliga möten i april och maj Immunicum AB (publ) meddelade idag att bolaget kommer att delta och...